Clonidine can reduce hot flash frequency by roughly 38% over eight weeks, which is modest but real. It’s a blood pressure medication that has been used off-label for hot flashes since the 1970s, and it remains an option for people who can’t or prefer not to use hormone therapy. That said, major menopause guidelines no longer recommend it as a go-to treatment because newer non-hormonal alternatives tend to work better.
How Clonidine Works on Hot Flashes
Hot flashes happen when the brain’s temperature regulation system narrows the range of body temperatures it considers “normal.” Small increases in core temperature that your body once ignored now trigger a cooling response: blood vessels dilate, your skin flushes, and you sweat. The hormone changes of menopause appear to make the brain more sensitive to these temperature shifts, partly through increased norepinephrine activity.
Clonidine acts on receptors in the brain that dial down norepinephrine release. By doing so, it raises the sweating threshold, meaning your body tolerates slightly higher core temperatures before launching into a hot flash. It doesn’t restore estrogen or fix the underlying hormonal shift, but it quiets the overactive signaling that triggers the flushing response.
How Much Relief to Expect
In a clinical trial of 194 postmenopausal women taking tamoxifen (a breast cancer drug known to worsen hot flashes), clonidine at 0.1 mg per day reduced hot flash frequency by 37% at four weeks and 38% at eight weeks. The placebo group saw a 20% to 24% reduction over the same periods. That 14 to 17 percentage point difference is statistically significant but not dramatic.
Notably, clonidine did not significantly reduce the severity or duration of individual hot flashes in that trial. When hot flashes still occurred, they felt about as intense and lasted about as long. In a smaller study using a clonidine skin patch, 80% of participants reported fewer hot flashes over eight weeks, and 73% reported less severity, suggesting the patch delivery may offer slightly different results. Most people notice improvement within the first four weeks of treatment.
How It Compares to Other Non-Hormonal Options
Clonidine sits toward the lower end of non-hormonal treatments in terms of effectiveness. Certain antidepressants perform considerably better. Paroxetine (the only one with specific FDA approval for hot flashes), citalopram, and escitalopram have been shown to reduce hot flash frequency by 10% to 64% depending on the study. Desvenlafaxine, another antidepressant, reduced frequency by 60% to 65% in clinical trials, putting it in the same range as low-dose hormone therapy. Venlafaxine achieved a 48% reduction, compared to 53% for estrogen, in a head-to-head study.
One interesting finding: in a 12-week comparison, venlafaxine worked faster, but clonidine actually showed greater overall reduction by the end of the study. So clonidine may have a slower ramp-up but can hold its own over a longer treatment period for some people.
The American College of Obstetricians and Gynecologists still lists clonidine as a non-hormonal option for reducing hot flashes and easing sleep problems. However, the North American Menopause Society’s 2023 position statement moved clonidine into its “not recommended” category for non-hormonal treatment of hot flashes, placing it alongside supplements, herbal remedies, and acupuncture. This doesn’t mean clonidine is unsafe or useless. It means the evidence doesn’t support it as strongly as other available options.
Who Might Still Benefit
Clonidine occupies a particular niche: people who cannot use hormone therapy and who either don’t tolerate antidepressants or have reasons to avoid them. Breast cancer survivors on tamoxifen are the most well-studied group. Hormone therapy raises concerns in this population, and some antidepressants can interfere with tamoxifen’s effectiveness. Clonidine sidesteps both of those issues. The trial data specifically in tamoxifen users confirmed a meaningful, if moderate, benefit.
If you already take clonidine for blood pressure, you may notice some hot flash relief as a secondary benefit. And because clonidine has mild sedating properties, it can help with the sleep disruption that often accompanies nighttime hot flashes.
Common Side Effects
The side effects of clonidine reflect what you’d expect from a drug that lowers blood pressure and calms the nervous system. Common ones include dry mouth, dry eyes, drowsiness, fatigue, dizziness or lightheadedness, headache, and low blood pressure. These effects tend to be dose-dependent, meaning they’re more likely at higher doses.
The most important safety concern is what happens when you stop taking it. Abruptly discontinuing clonidine can cause a rebound spike in blood pressure, even in people who had normal blood pressure before starting the medication. Both the North American Menopause Society and the Endocrine Society specifically warn against sudden cessation. If you decide to stop, your prescriber will taper the dose gradually over several days to a couple of weeks.
Typical Dosing
The usual starting dose for hot flashes is 25 micrograms twice daily, which is a quarter of a standard tablet. This can be increased to 50 micrograms twice daily, with a maximum total daily dose of 150 micrograms. For context, blood pressure treatment often uses higher doses, so the hot flash dosing is relatively low. Clonidine is also available as a skin patch that delivers the medication steadily over a week, which some people find more convenient and may produce fewer peaks and valleys in side effects.
Most clinicians start at the lowest dose and increase only if needed, since side effects like drowsiness and dry mouth often determine how high you can comfortably go. Improvement typically begins within the first four weeks, so if you’ve been on a stable dose for two months with no change in your hot flashes, the medication likely isn’t going to work for you.